Skip to content

Moat Ross

Reporting owner on Forms 3, 4 and 5, CIK 1857177.

Moat Ross reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-03.

Issuers

IssuerRoles in the latest filingFilingsLast filed
KNSA · Kiniksa Pharmaceuticals International, plcCIK 1730430officer (CHIEF OPERATING OFFICER)12026-11-03

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-02M exercised+9,412$18.0619,706Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-02M exercised+12,302$21.7732,008Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-02M exercised+6,263$22.8938,271Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-02S sold-6,681$91.2331,590Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-02S sold-8,932$92.0522,658Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-02S sold-11,642$93.1511,016Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-02S sold-722$94.0510,294Form 4
KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative2026-11-02M exercised-9,412$015,793Form 4
KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative2026-11-02M exercised-12,302$027,062Form 4
KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative2026-11-02M exercised-6,263$01,691Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-10-30M exercised+16,111$10.7632,418Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-10-30M exercised+21,059$11.153,477Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-10-30M exercised+3,760$11.9757,237Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-10-30M exercised+1,658$12.9758,895Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-10-30M exercised+16,112$17.7675,007Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-10-30M exercised+10,895$18.0685,902Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-10-30S sold-37,775$9248,127Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-10-30S sold-15,114$92.8133,013Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-10-30S sold-8,430$93.9724,583Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-10-30S sold-6,282$94.9218,301Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-10-30S sold-3,672$96.0314,629Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-10-30S sold-1,760$97.112,869Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-10-30S sold-2,575$97.7610,294Form 4
KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative2026-10-30M exercised-16,111$07,250Form 4
KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative2026-10-30M exercised-21,059$00Form 4
KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative2026-10-30M exercised-3,760$023,492Form 4
KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative2026-10-30M exercised-1,658$00Form 4
KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative2026-10-30M exercised-16,112$011,277Form 4
KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative2026-10-30M exercised-10,895$025,205Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001857177-26-000010 Kiniksa Pharmaceuticals International, plc2026-11-03